Axsome Therapeutics Inc. (AXSM) NASDAQ
$71.17 (1.91) (-2.61%)
Market Cap: $3.37B
As of 04/24/24 04:00 PM EDT. Market closed.
Axsome Therapeutics Inc. (AXSM)
NASDAQ
$71.17
(1.91) (-2.61%)
Market Cap: $3.37B
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Herriot Tabuteau
Full Time Employees
353
CEO Compensation (Base)
$435,000
CEO Compensation (Total)
$1.06M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Herriot Tabuteau
Full Time Employees
353
CEO Compensation (Base)
$435,000
CEO Compensation (Total)
$1.06M
URL
Address
22 Cortlandt Street, 16Th Floor, New York, New York, 10007.
PRICE CHART FOR AXSOME THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$72.46
Previous Close
$73.08
Days Range
$69.96 - $72.61
52 week range
$55.02 - $98.40
Volume
583,799
Avg. Volume (30 days)
569,991
Market Cap
$3.37B
Dividend Yield
-
P/E
(14.09)
Shares Outstanding
47,374,375
Open
$72.46
Previous Close
$73.08
Days Range
$69.96 - $72.61
52 week range
$55.02 - $98.40
Volume
583,799
Avg. Volume (30 days)
569,991
Market Cap
$3.37B
Dividend Yield
-
P/E
(14.09)
Shares Outstanding
47,374,375
FINANCIAL STATEMENTS FOR AXSOME THERAPEUTICS INC
LOADING...
INSIDER TRANSACTIONS FOR AXSOME THERAPEUTICS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Jacobson Mark L. | Chief Operating Officer | Apr 01, 2024 | Option Exercise | $1.30 | 24,662 | 32,061 | 24,662 | Apr 01, 2024, 06:46 PM |
Jacobson Mark L. | Chief Operating Officer | Apr 01, 2024 | Sale | $77.24 | 24,662 | 1,904,942 | 0 | Apr 01, 2024, 06:46 PM |
JEFFS ROGER | Director | Mar 15, 2024 | Option Exercise | $29.91 | 2,347 | 70,199 | 123,103 | Mar 15, 2024, 08:05 PM |
JEFFS ROGER | Director | Mar 14, 2024 | Option Exercise | $24.01 | 29,976 | 719,787 | 137,732 | Mar 15, 2024, 08:05 PM |
JEFFS ROGER | Director | Mar 15, 2024 | Sale | $71.61 | 2,347 | 168,062 | 120,756 | Mar 15, 2024, 08:05 PM |
JEFFS ROGER | Director | Mar 14, 2024 | Sale | $69.70 | 29,976 | 2,089,387 | 120,756 | Mar 15, 2024, 08:05 PM |
Coleman Mark | Director | Sep 15, 2023 | Option Exercise | $3.67 | 11,016 | 40,429 | 36,113 | Sep 15, 2023, 06:30 PM |
Coleman Mark | Director | Sep 15, 2023 | Sale | $75.18 | 18,572 | 1,396,189 | 403,856 | Sep 15, 2023, 06:30 PM |
Coleman Mark | Director | Sep 15, 2023 | Sale | $75.19 | 11,016 | 828,241 | 25,097 | Sep 15, 2023, 06:30 PM |
Coleman Mark | Director | Jan 03, 2023 | Option Exercise | $1.30 | 17,501 | 22,751 | 25,097 | Jan 04, 2023, 04:11 PM |
Coleman Mark | Director | Mar 15, 2022 | Option Exercise | $1.30 | 3,496 | 4,545 | 7,596 | Mar 17, 2022, 07:05 AM |
JEFFS ROGER | Director | Nov 19, 2021 | Buy | $37.30 | 3,950 | 147,350 | 120,756 | Nov 23, 2021, 07:30 AM |
Pizzie Nick | CHIEF FINANCIAL OFFICER | Nov 18, 2021 | Buy | $34.97 | 428 | 14,968 | 201 | Nov 22, 2021, 07:31 AM |
Pizzie Nick | CHIEF FINANCIAL OFFICER | Nov 18, 2021 | Buy | $35.50 | 527 | 18,709 | 41,789 | Nov 22, 2021, 07:31 AM |
Coleman Mark | Director | Nov 18, 2021 | Buy | $35.09 | 1,430 | 50,181 | 422,428 | Nov 22, 2021, 07:30 AM |
Saad Mark E | Director | Nov 17, 2021 | Buy | $34.42 | 300 | 10,325 | 100 | Nov 19, 2021, 07:30 AM |
Saad Mark E | Director | Nov 17, 2021 | Buy | $34.53 | 3,000 | 103,597 | 10,002 | Nov 19, 2021, 07:30 AM |
Coleman Mark | Director | May 12, 2021 | Buy | $58.15 | 500 | 29,075 | 420,998 | May 13, 2021, 07:05 AM |
Coleman Mark | Director | Jun 29, 2020 | Buy | $78.50 | 650 | 51,025 | 403,698 | Jun 30, 2020, 08:20 AM |
Pizzie Nick | Chief Financial Officer | Jun 29, 2020 | Buy | $76.64 | 777 | 59,549 | 41,217 | Jun 30, 2020, 08:19 AM |
JEFFS ROGER | Director | Jan 10, 2020 | Option Exercise | $10.46 | 60,186 | 629,756 | 116,806 | Jan 14, 2020, 04:08 PM |
Pizzie Nick | Chief Financial Officer | Sep 26, 2019 | Buy | $24.80 | 2,180 | 54,064 | 40,440 | Sep 30, 2019, 07:16 AM |
JEFFS ROGER | Director | Jul 03, 2019 | Option Exercise | $3.04 | 56,620 | 172,178 | 56,620 | Jul 05, 2019, 07:00 AM |
Coleman Mark | Director | Jun 26, 2019 | Buy | $23.10 | 15,800 | 364,980 | 668,848 | Jun 27, 2019, 07:18 AM |
Coleman Mark | Director | Jun 25, 2019 | Buy | $23.25 | 400 | 9,300 | 653,048 | Jun 27, 2019, 07:18 AM |
Pizzie Nick | Chief Financial Officer | Jun 11, 2019 | Buy | $20.80 | 1,920 | 39,936 | 1,920 | Jun 12, 2019, 07:00 AM |
Saad Mark E | Director | May 23, 2019 | Buy | $22.33 | 3,500 | 78,155 | 7,002 | May 24, 2019, 07:19 AM |
Coleman Mark | Director | May 13, 2019 | Buy | $21.44 | 4,650 | 99,696 | 652,648 | May 15, 2019, 07:21 AM |
Pizzie Nick | Chief Financial Officer | Mar 19, 2019 | Buy | $12.58 | 5,340 | 67,177 | 36,340 | Mar 21, 2019, 07:05 AM |
Pizzie Nick | Chief Financial Officer | Mar 19, 2019 | Buy | $12.69 | 60 | 761 | 60 | Mar 21, 2019, 07:05 AM |
Coleman Mark | Director | Mar 19, 2019 | Buy | $12.18 | 5,100 | 62,118 | 5,100 | Mar 21, 2019, 07:05 AM |
Pizzie Nick | Chief Financial Officer | Jun 19, 2018 | Buy | $3.10 | 31,000 | 96,080 | 31,000 | Jun 20, 2018, 05:00 PM |
JEFFS ROGER | Director | Mar 29, 2017 | Option Exercise | $4.73 | 42,538 | 201,163 | 46,912 | Mar 30, 2017, 04:31 PM |
Kaye Randall | Chief Medical Officer | Dec 23, 2015 | Buy | $9.03 | 1,000 | 9,026 | 6,022 | Dec 24, 2015, 01:02 PM |
Ames Constance | Vice President, Finance | Nov 24, 2015 | Option Exercise | $5.94 | 4,358 | 25,887 | 4,358 | Nov 24, 2015, 04:26 PM |
Kaye Randall | Chief Medical Officer | Nov 24, 2015 | Option Exercise | $5.40 | 5,022 | 27,119 | 5,022 | Nov 24, 2015, 04:26 PM |
Coleman Mark | Director | Nov 24, 2015 | Option Exercise | $5.71 | 564,948 | 3,224,166 | 647,998 | Nov 24, 2015, 04:25 PM |
JEFFS ROGER | Director | Nov 24, 2015 | Option Exercise | $5.94 | 4,374 | 25,982 | 4,374 | Nov 24, 2015, 04:25 PM |
Saad Mark E | Director | Nov 24, 2015 | Option Exercise | $5.94 | 3,502 | 20,802 | 3,502 | Nov 24, 2015, 04:24 PM |
TABUTEAU HERRIOT | Chief Executive Officer | Nov 24, 2015 | Option Exercise | $5.94 | 7,229 | 42,940 | 7,229 | Nov 24, 2015, 04:24 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Jacobson Mark L. | Chief Operating Officer | 04/01/2024 | 32,061 |
Jacobson Mark L. | Chief Operating Officer | 04/01/2024 | 1,904,942 |
JEFFS ROGER | Director | 03/15/2024 | 70,199 |
JEFFS ROGER | Director | 03/14/2024 | 719,787 |
JEFFS ROGER | Director | 03/15/2024 | 168,062 |
JEFFS ROGER | Director | 03/14/2024 | 2,089,387 |
Coleman Mark | Director | 09/15/2023 | 40,429 |
Coleman Mark | Director | 09/15/2023 | 1,396,189 |
Coleman Mark | Director | 09/15/2023 | 828,241 |
Coleman Mark | Director | 01/03/2023 | 22,751 |
Coleman Mark | Director | 03/15/2022 | 4,545 |
JEFFS ROGER | Director | 11/19/2021 | 147,350 |
Pizzie Nick | CHIEF FINANCIAL OFFICER | 11/18/2021 | 14,968 |
Pizzie Nick | CHIEF FINANCIAL OFFICER | 11/18/2021 | 18,709 |
Coleman Mark | Director | 11/18/2021 | 50,181 |
Saad Mark E | Director | 11/17/2021 | 10,325 |
Saad Mark E | Director | 11/17/2021 | 103,597 |
Coleman Mark | Director | 05/12/2021 | 29,075 |
Coleman Mark | Director | 06/29/2020 | 51,025 |
Pizzie Nick | Chief Financial Officer | 06/29/2020 | 59,549 |
JEFFS ROGER | Director | 01/10/2020 | 629,756 |
Pizzie Nick | Chief Financial Officer | 09/26/2019 | 54,064 |
JEFFS ROGER | Director | 07/03/2019 | 172,178 |
Coleman Mark | Director | 06/26/2019 | 364,980 |
Coleman Mark | Director | 06/25/2019 | 9,300 |
Pizzie Nick | Chief Financial Officer | 06/11/2019 | 39,936 |
Saad Mark E | Director | 05/23/2019 | 78,155 |
Coleman Mark | Director | 05/13/2019 | 99,696 |
Pizzie Nick | Chief Financial Officer | 03/19/2019 | 67,177 |
Pizzie Nick | Chief Financial Officer | 03/19/2019 | 761 |
Coleman Mark | Director | 03/19/2019 | 62,118 |
Pizzie Nick | Chief Financial Officer | 06/19/2018 | 96,080 |
JEFFS ROGER | Director | 03/29/2017 | 201,163 |
Kaye Randall | Chief Medical Officer | 12/23/2015 | 9,026 |
Ames Constance | Vice President, Finance | 11/24/2015 | 25,887 |
Kaye Randall | Chief Medical Officer | 11/24/2015 | 27,119 |
Coleman Mark | Director | 11/24/2015 | 3,224,166 |
JEFFS ROGER | Director | 11/24/2015 | 25,982 |
Saad Mark E | Director | 11/24/2015 | 20,802 |
TABUTEAU HERRIOT | Chief Executive Officer | 11/24/2015 | 42,940 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AXSOME THERAPEUTICS INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,239,746 | 0.00657% | 10.4% | Other |
RA CAPITAL MANAGEMENT, L.P. | 1,000,000 | 1.24% | No change | Other |
GEODE CAPITAL MANAGEMENT, LLC | 822,304 | 0.00685% | 5.63% | Other |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 365,000 | 0.06% | 12.31% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 265,842 | 0.25% | 6.81% | Growth |
WCM INVESTMENT MANAGEMENT, LLC | 104,808 | 0.02% | 9.22% | Growth At A Reasonable Price |
CANDRIAM S.C.A. | 85,084 | 0.05% | 69.88% | Other |
D. E. SHAW & CO., INC. | 34,600 (Call) | 0.00241% | No change | Other |
ALPS ADVISORS INC | 32,482 | 0.02% | -6.74% | Other |
UBS OCONNOR LLC | 11,922 | 0.07% | -53.67% | Value |
D. E. SHAW & CO., INC. | 9,184 | 0.00064% | New | Other |
AQR CAPITAL MANAGEMENT LLC | 8,330 | 0.00125% | -14.66% | Other |
FARALLON CAPITAL MANAGEMENT LLC | 4,000 | 0.00158% | -96.82% | Event Driven, Value |
CHANGE IN SHARES OUTSTANDING FOR AXSOME THERAPEUTICS INC
STOCK BUYBACKS FOR AXSOME THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.50%
1Q
06/30/2023
8.43%
2Q
03/31/2023
8.79%
3Q
12/31/2022
8.91%
4Q
09/30/2022
13.54%
5Q
06/30/2022
21.16%
6Q
03/31/2022
23.56%
7Q
12/31/2021
25.38%
8Q
09/30/2021
25.66%
9Q
06/30/2021
25.95%
10Q
03/31/2021
26.51%
11Q
12/31/2020
26.77%
12Q
09/30/2020
26.91%
13Q
06/30/2020
27.63%
14Q
03/31/2020
27.76%
15Q
12/31/2019
36.20%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AXSOME THERAPEUTICS INC
LOADING...